Skip to main content

Table 1 Participation of volunteers in the HIVIS-03 trial

From: Experiences on recruitment and retention of volunteers in the first HIV vaccine trial in Dar es Salam, Tanzania - the phase I/II HIVIS 03 trial

Volunteers who: Males (%) Females (%) Total (100%)
Attended for Screening 128 (72.3%) 49 (27.7%) 177 (100%)
Screened with available Lab test results 119 (73.5%) 43 (26.5%) 162 (100%)
Randomized 57 (72.2%) 22 (27.8%) 79 (100%)
Exited after Randomization 12 (63.2%) 7 (36.8%) 19 (100%)
Enrolled & received 1st DNA/Placebo vaccination 45 (75%) 15 (25%) 60 (100%)
Screening: Enrolment 2.8:1 3.3:1 3.0:1